DK15388A - Fremgangsmaade til fremstilling af et forsinkelsesprodukt indeholdende diltiazem med en saerlig daglig dosering - Google Patents

Fremgangsmaade til fremstilling af et forsinkelsesprodukt indeholdende diltiazem med en saerlig daglig dosering

Info

Publication number
DK15388A
DK15388A DK015388A DK15388A DK15388A DK 15388 A DK15388 A DK 15388A DK 015388 A DK015388 A DK 015388A DK 15388 A DK15388 A DK 15388A DK 15388 A DK15388 A DK 15388A
Authority
DK
Denmark
Prior art keywords
preparation
procedure
product containing
daily dosage
delay product
Prior art date
Application number
DK015388A
Other languages
English (en)
Other versions
DK15388D0 (da
DK173505B1 (da
Inventor
Dieter Barth
Original Assignee
Varnel Chem Business Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Varnel Chem Business Sa filed Critical Varnel Chem Business Sa
Publication of DK15388D0 publication Critical patent/DK15388D0/da
Publication of DK15388A publication Critical patent/DK15388A/da
Application granted granted Critical
Publication of DK173505B1 publication Critical patent/DK173505B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DK198800153A 1987-02-20 1988-01-13 Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t DK173505B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH63787 1987-02-20
CH63787 1987-02-20

Publications (3)

Publication Number Publication Date
DK15388D0 DK15388D0 (da) 1988-01-13
DK15388A true DK15388A (da) 1988-08-21
DK173505B1 DK173505B1 (da) 2001-01-15

Family

ID=4191649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198800153A DK173505B1 (da) 1987-02-20 1988-01-13 Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t

Country Status (12)

Country Link
EP (1) EP0282698B1 (da)
JP (1) JP2863528B2 (da)
KR (1) KR960011232B1 (da)
AT (1) ATE172112T1 (da)
AU (1) AU1196988A (da)
BR (1) BR8800763A (da)
CA (1) CA1327006C (da)
DE (1) DE3856258T2 (da)
DK (1) DK173505B1 (da)
ES (1) ES2125215T3 (da)
MX (1) MX10490A (da)
ZA (1) ZA881181B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
DE3922167A1 (de) * 1988-04-16 1991-01-17 Sanol Arznei Schwarz Gmbh Oral zu verabreichende diltiazemhydrochlorid enthaltende pharmazeutische zubereitung zur einmal taeglichen applikation und verfahren zu deren herstellung
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
SE8902699D0 (sv) * 1989-08-09 1989-08-09 Lejus Medical Ab Diltiazem containing pharmaceutical compositios
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
JP3746315B2 (ja) 1994-07-07 2006-02-15 ダイセル化学工業株式会社 分離剤
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
DE69722191T2 (de) * 1996-03-08 2004-04-01 Nycomed Danmark Aps Dosiszusammensetzung mit modifizierter freigabe aus vielen einzelkomponenten
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle
EP1010457A4 (en) 1996-12-10 2006-03-22 Asahi Chemical Ind POROUS POLYVINYLIDE FLUORIDE RESIN FILM AND METHOD FOR THE PRODUCTION THEREOF
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
US7108866B1 (en) * 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio

Also Published As

Publication number Publication date
KR960011232B1 (ko) 1996-08-21
DK15388D0 (da) 1988-01-13
DK173505B1 (da) 2001-01-15
KR880009640A (ko) 1988-10-04
ATE172112T1 (de) 1998-10-15
BR8800763A (pt) 1988-10-04
ZA881181B (en) 1988-08-16
JPH01216934A (ja) 1989-08-30
DE3856258T2 (de) 1999-04-29
AU1196988A (en) 1988-08-25
MX10490A (es) 1993-12-01
DE3856258D1 (de) 1998-11-19
JP2863528B2 (ja) 1999-03-03
EP0282698A1 (fr) 1988-09-21
EP0282698B1 (fr) 1998-10-14
ES2125215T3 (es) 1999-03-01
CA1327006C (en) 1994-02-15

Similar Documents

Publication Publication Date Title
DK15388D0 (da) Fremgangsmaade til fremstilling af et forsinkelsesprodukt indeholdende diltiazem med en saerlig daglig dosering
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
IL96900A0 (en) Pharmaceutical composition containing naproxen
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
NO890194L (no) Galenisk middel.
IL88083A0 (en) Controlled release pharmaceutical dosage form and its preparation
KR860001591A (ko) 펠렛 제제물 및 그의 제조방법
AP9400645A0 (en) Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release sold dosage forms of medicaments prepared thereby.
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
NO821084L (no) Fremgangsmaate for fremstilling av galenisk preparat med konstant virkestoff-frigjoering
HK134494A (en) Substituted release azelastine containing medicaments
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
AU4620293A (en) Programmed release tablets containing naproxen
DE68915094D1 (de) Benzofuranverbindungen, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische und kosmetische Zusammenstellungen und Verwendung dieser Zusammenstellungen.
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
MY114610A (en) Controlled drug delivery system for diltiazem.
RU96123569A (ru) Лекарственный препарат
IT1270592B (it) Formulazione a rilascio modificato per la somministrazione di farmaci antiinfiammatori non steroidei

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK